Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dorien de Clippel"'
Autor:
Elise Wouters, Caro Verbrugghe, Rana Abdelnabi, Rosalie Devloo, Dorien De Clippel, Dirk Jochmans, Dominique De Bleser, Birgit Weynand, Veerle Compernolle, Johan Neyts, Hendrik B. Feys
Publikováno v:
EBioMedicine, Vol 92, Iss , Pp 104597- (2023)
Summary: Background: Convalescent plasma (CP) transfusion is an early option for treating infections with pandemic potential, often preceding vaccine or antiviral drug rollout. Heterogenous findings from randomized clinical trials on transfusion of C
Externí odkaz:
https://doaj.org/article/5d9886d29eb34feeaa7c20447ab24371
Autor:
Marieke Vinkenoog, Jarkko Toivonen, Tinus Brits, Dorien de Clippel, Veerle Compernolle, Surendra Karki, Marijke Welvaert, Amber Meulenbeld, Katja van den Hurk, Joost van Rosmalen, Emmanuel Lesaffre, Mikko Arvas, Mart Janssen
Publikováno v:
Vox Sanguinis. Wiley-Blackwell Publishing Ltd
VOX SANGUINIS
VOX SANGUINIS
Background and Objectives: Blood banks use a haemoglobin (Hb) threshold before blood donation to minimize donors' risk of anaemia. Hb prediction models may guide decisions on which donors to invite, and should ideally also be generally applicable, th
Autor:
Veerle Compernolle, Elise Wouters, An Muylaert, Miek Vanbrabant, Kristin Van Asch, Véronique Van Gaver, Rosalie Devloo, Caro Verbrugghe, Hendrik B. Feys, Dorien De Clippel, Isabelle Debruyne, Leen Van Heddegem
Publikováno v:
Transfusion
TRANSFUSION
TRANSFUSION
Background COVID‐19 convalescent plasma (CCP) ideally contains high titers of (neutralizing) anti‐SARS‐CoV‐2 antibodies. Several scalable immunoassays for CCP selection have been developed. We designed an enzyme‐linked immunosorbent assay (
Autor:
Giovani Vandewalle, Philippe Vandekerckhove, Leen Van Heddegem, Dorien De Clippel, Veerle Compernolle
Publikováno v:
Transfusion. 57:938-945
Background Low hemoglobin (Hb) levels are a common reason for whole blood donor deferral. As some of the deferred donors do not return to donate blood later, the development of accurate tools to reliably detect low Hb levels is therefore important fo
BACKGROUND: Transfusion-related acute lung injury (TRALI) is a rare but serious adverse transfusion reaction and is known to be related to anti-human leukocyte antigen (HLA) or anti-human neutrophil antigen (HNA) antibodies in donor plasma. In 2016,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::badb950f2f75790355c79096cc960de2
https://lirias.kuleuven.be/handle/123456789/654188
https://lirias.kuleuven.be/handle/123456789/654188
Autor:
Hendrik B. Feys, Martine Baeten, Veerle Compernolle, Philippe Vandekerckhove, Anneleen Torfs, Marie-Paule Emonds, Dorien De Clippel
Publikováno v:
Transfusion. 54:3036-3042
Background Transfusion-related acute lung injury (TRALI) is known as a life-threatening complication of transfusion. HLA and HNA antibodies have been associated with the immune pathway of TRALI. Since donors with a history of transfusion and/or pregn
Autor:
Dorien, De Clippel, Leen, Van Heddegem, Giovani, Vandewalle, Philippe, Vandekerckhove, Veerle, Compernolle
Publikováno v:
Transfusion. 57(4)
Low hemoglobin (Hb) levels are a common reason for whole blood donor deferral. As some of the deferred donors do not return to donate blood later, the development of accurate tools to reliably detect low Hb levels is therefore important for donor saf
Autor:
Dorien, De Clippel, Martine, Baeten, Anneleen, Torfs, Marie-Paule, Emonds, Hendrik B, Feys, Veerle, Compernolle, Philippe, Vandekerckhove
Publikováno v:
Transfusion. 54(12)
Transfusion-related acute lung injury (TRALI) is known as a life-threatening complication of transfusion. HLA and HNA antibodies have been associated with the immune pathway of TRALI. Since donors with a history of transfusion and/or pregnancy are pr